Technological innovations like Artificial Intelligence are set to change the way clinical trials are conducted in the pharma industry. Besides this, 3D printing and new innovations like portable ECG machines are also going to help patients to have early detection of heart disease, says Ravi Sharma, CIO of Marksans Pharma Ltd, in conversation with Elets News Network (ENN).
How the pharmaceutical industry is being impacted by innovations in technology?
In pharmaceutical industry, one has to innovate keeping in mind the ‘Right First Time’ concept because rewards for success are very high and the failure of innovation is linked to the very survival of the company. For every molecule, filing first for the patent pays a very high dividend.
Information, research and new manufacturing techniques are some of the important drivers of growth for the pharmaceutical industry and theft of such important data can be a real-threat. So, how do you develop and implement potential security solutions to identify and mitigate such risks?
Intellectual property is the bread and butter of the pharma industry. Therefore, it is imperative to protect the intellectual property using technology. We have been using data leak prevention tools in our organisation to secure such data.
What kind of latest innovations are you implementing in your manufacturing facilities and R&D centres?
We are in the process of setting up a full-fledged R&D centre. But in the meantime, we have implemented solutions like document management system, empower systems and lab solutions software, etc to boost our efficiency.
How technological advancements have brought in new opportunities for drug manufacturing and to bolster R&D efforts in the sector?
Currently, clinical trials are carried out on subjects. But in near future using Artificial Intelligence the trials may be conducted through simulation models. 3D printing will also help in proper diagnostic and accurate treatment of patients. Recently, new innovations like portable ECG machine that can fit into palm and send the ECG report to your doctor have also gained popularity. This will help patients to have early detection of heart disease.
“Intellectual property is the bread and butter of the pharma industry. Therefore, it is imperative to protect the intellectual property using technology. We have been using data leak prevention tools in our organisation to secure such data.”
Please apprise us on the major issues linked to the increased usage of cloud computing in the pharmaceutical industry.
Presently, there are some regulatory requirements like the data should be stored within the country and proper backup schedule is acceptable to the data owner. However besides that, there should be more stringent SLAs (service-level agreements) with the vendor with proper exit clause. It should also be ensured that the data is recoverable in the format that you can read at the time of contract termination. Data security is another concern which needs to be looked into.
How ICT is being leveraged to enhance the industry’s offerings and growth?
Mobile technologies can potentially act as a catalyst to increase the impact of digital offerings when they are applied. Digitisation of data and its availability when it is needed is another offering which will helps pharma industry’s growth.